Millennium Management’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
AC
PAG
VF
Millennium Management's CODX Position: Q2 2026 in Review
Millennium Management opened a new position in Co-Diagnostics (CODX) in Q2 2026: 31,995 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #5505 among its holdings. This is a return to the name: Millennium Management previously reported a position in CODX as recently as Q4 2023.
Millennium Management first reported a position in CODX in Q3 2017 and has held it in 18 quarters since. The position peaked at $7.34M in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.
- Millennium Management held 31,995 shares of Co-Diagnostics worth $99.2K as of Q2 2026.
- Co-Diagnostics was a new Millennium Management position in Q2 2026.
- Co-Diagnostics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5505 holding.
- Millennium Management first reported a position in Co-Diagnostics in Q3 2017 and has held it in 18 quarters since.
- Millennium Management's Co-Diagnostics position peaked at $7.34M in Q3 2021.
- 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.